Bone disease in testicular and extragonadal germ cell tumours.
Of 297 patients with metastatic testicular and extragonadal germ cell tumours (GCT), bone involvement was detected clinically in 3% (7/251) of those at first presentation and in 9% (4/46) of relapsed cases. This difference was not statistically significant (95% confidence limits -2%; +14%). Concurre...
Main Authors: | Hitchins, R. N., Philip, P. A., Wignall, B., Newlands, E. S., Begent, R. H., Rustin, G. J., Bagshawe, K. D. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1988
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246879/ |
Similar Items
-
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
by: Hitchins, R. N., et al.
Published: (1989) -
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
by: Crawford, S. M., et al.
Published: (1989) -
Atypical extragonadal germ cell tumors
by: Deb, Mainak, et al.
Published: (2012) -
Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?
by: Guindalini, Rodrigo Santa Cruz, et al.
Published: (2013) -
The role of surgery in metastatic testicular germ cell tumours (GCT).
by: Newlands, E. S., et al.
Published: (1989)